Natixis Advisors LLC Sells 18,668 Shares of Azenta, Inc. (NASDAQ:AZTA)

Natixis Advisors LLC decreased its holdings in shares of Azenta, Inc. (NASDAQ:AZTA) by 4.7% during the third quarter, according to the company in its most recent disclosure with the SEC. The fund owned 378,450 shares of the company’s stock after selling 18,668 shares during the quarter. Natixis Advisors LLC owned 0.77% of Azenta worth $18,332,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently modified their holdings of AZTA. Hantz Financial Services Inc. purchased a new stake in shares of Azenta during the 2nd quarter valued at $30,000. Farther Finance Advisors LLC raised its stake in Azenta by 20.0% in the 3rd quarter. Farther Finance Advisors LLC now owns 1,537 shares of the company’s stock worth $74,000 after acquiring an additional 256 shares during the last quarter. Benjamin F. Edwards & Company Inc. raised its stake in Azenta by 150.9% in the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 1,588 shares of the company’s stock worth $84,000 after acquiring an additional 955 shares during the last quarter. Lazard Asset Management LLC purchased a new position in Azenta in the 1st quarter worth $130,000. Finally, Acadian Asset Management LLC raised its stake in shares of Azenta by 24.7% during the 1st quarter. Acadian Asset Management LLC now owns 2,381 shares of the company’s stock valued at $143,000 after buying an additional 471 shares during the last quarter. Institutional investors own 99.08% of the company’s stock.

Analyst Ratings Changes

A number of research firms have weighed in on AZTA. Evercore ISI reduced their price objective on Azenta from $53.00 to $50.00 and set an “in-line” rating for the company in a research note on Tuesday, October 1st. Needham & Company LLC dropped their target price on Azenta from $69.00 to $55.00 and set a “buy” rating on the stock in a research report on Wednesday, November 13th. Three investment analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $63.60.

Insider Buying and Selling

In other news, CEO John Marotta purchased 12,717 shares of the business’s stock in a transaction that occurred on Monday, November 18th. The stock was purchased at an average cost of $39.48 per share, with a total value of $502,067.16. Following the completion of the acquisition, the chief executive officer now directly owns 99,612 shares of the company’s stock, valued at approximately $3,932,681.76. This trade represents a 14.63 % increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director William L. Cornog purchased 12,500 shares of the business’s stock in a transaction that occurred on Monday, November 18th. The shares were purchased at an average cost of $39.60 per share, with a total value of $495,000.00. Following the completion of the acquisition, the director now directly owns 14,755 shares of the company’s stock, valued at $584,298. This represents a 554.32 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders own 1.77% of the company’s stock.

Azenta Stock Up 1.3 %

Shares of NASDAQ AZTA opened at $40.91 on Wednesday. The firm has a market cap of $2.00 billion, a price-to-earnings ratio of -13.77 and a beta of 1.48. Azenta, Inc. has a 52-week low of $38.82 and a 52-week high of $69.16. The business’s 50 day moving average is $45.34 and its two-hundred day moving average is $50.26.

Azenta (NASDAQ:AZTA) last posted its quarterly earnings results on Tuesday, November 12th. The company reported $0.18 EPS for the quarter, topping the consensus estimate of $0.10 by $0.08. The business had revenue of $170.00 million during the quarter, compared to the consensus estimate of $169.66 million. Azenta had a negative net margin of 25.01% and a positive return on equity of 1.03%. The company’s quarterly revenue was down 1.2% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.13 earnings per share. Analysts anticipate that Azenta, Inc. will post 0.4 EPS for the current fiscal year.

Azenta Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.